Claude Bron

6.0k total citations · 1 hit paper
80 papers, 5.1k citations indexed

About

Claude Bron is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Claude Bron has authored 80 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 44 papers in Immunology and 27 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Claude Bron's work include Monoclonal and Polyclonal Antibodies Research (27 papers), Glycosylation and Glycoproteins Research (21 papers) and T-cell and B-cell Immunology (17 papers). Claude Bron is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (27 papers), Glycosylation and Glycoproteins Research (21 papers) and T-cell and B-cell Immunology (17 papers). Claude Bron collaborates with scholars based in Switzerland, United States and France. Claude Bron's co-authors include H. Robson MacDonald, Irina Nikonenko, Nicolas Toni, Dominique Müller, Pierre‐Alain Buchs, Daniel F. Legler, Marie‐Agnès Doucey, Andrew F. G. Quest, Jürg Tschopp and Rawleigh Howe and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Claude Bron

80 papers receiving 4.9k citations

Hit Papers

LTP promotes formation of multiple spine synapses between... 1999 2026 2008 2017 1999 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claude Bron Switzerland 32 2.3k 2.2k 754 752 574 80 5.1k
Ned Mantei Switzerland 40 941 0.4× 2.9k 1.3× 467 0.6× 912 1.2× 378 0.7× 58 5.5k
Dennis Huszar United States 42 1.7k 0.8× 3.1k 1.4× 1.1k 1.4× 369 0.5× 763 1.3× 86 8.7k
Noah Sciaky United States 24 1.7k 0.7× 2.9k 1.3× 1.2k 1.6× 682 0.9× 326 0.6× 39 5.4k
Burkhart Schraven Germany 49 4.3k 1.9× 3.2k 1.5× 557 0.7× 329 0.4× 519 0.9× 200 7.7k
Phyllis Gardner United States 35 1.0k 0.4× 3.2k 1.5× 260 0.3× 986 1.3× 212 0.4× 67 5.8k
Peter Adamson United Kingdom 43 946 0.4× 2.9k 1.3× 808 1.1× 702 0.9× 491 0.9× 99 5.8k
Maria A. Bednarek United States 31 1.3k 0.6× 2.3k 1.1× 333 0.4× 297 0.4× 465 0.8× 64 5.1k
Wai T. Wong United States 56 1.1k 0.5× 4.1k 1.9× 697 0.9× 1.4k 1.9× 2.8k 4.9× 188 10.5k
Isabella A. Graef United States 29 965 0.4× 4.1k 1.9× 573 0.8× 928 1.2× 109 0.2× 39 5.8k
Robert A. Hipskind France 44 919 0.4× 3.7k 1.7× 364 0.5× 948 1.3× 147 0.3× 77 5.5k

Countries citing papers authored by Claude Bron

Since Specialization
Citations

This map shows the geographic impact of Claude Bron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Bron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Bron more than expected).

Fields of papers citing papers by Claude Bron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Bron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Bron. The network helps show where Claude Bron may publish in the future.

Co-authorship network of co-authors of Claude Bron

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Bron. A scholar is included among the top collaborators of Claude Bron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Bron. Claude Bron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doucey, Marie‐Agnès, et al.. (2006). Caveolin-1 interacts with the chaperone complex TCP-1 and modulates its protein folding activity. Cellular and Molecular Life Sciences. 63(7-8). 939–948. 12 indexed citations
2.
Legler, Daniel F., et al.. (2004). The α vβ 3 integrin as a tumor homing ligand for lymphocytes. European Journal of Immunology. 34(6). 1608–1616. 26 indexed citations
3.
Doucey, Marie‐Agnès, Léonardo Scarpellino, Jacques Zimmer, et al.. (2004). Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nature Immunology. 5(3). 328–336. 153 indexed citations
4.
Legler, Daniel F., Olivier Micheau, Marie‐Agnès Doucey, Jürg Tschopp, & Claude Bron. (2003). Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation. Immunity. 18(5). 655–664. 376 indexed citations
5.
Rothenberger, Sylvia, et al.. (2003). Ubiquitination of the Epstein–Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site. Oncogene. 22(36). 5614–5618. 15 indexed citations
6.
Doucey, Marie‐Agnès, Daniel F. Legler, Mustapha Faroudi, et al.. (2003). The β1 and β3 Integrins Promote T Cell Receptor-mediated Cytotoxic T Lymphocyte Activation. Journal of Biological Chemistry. 278(29). 26983–26991. 58 indexed citations
7.
Rothenberger, Sylvia, et al.. (2002). Association of the Epstein-Barr virus latent membrane protein 1 with lipid rafts is mediated through its N-terminal region. Cellular and Molecular Life Sciences. 59(1). 171–180. 14 indexed citations
8.
Gaide, Olivier, Benoı̂t Favier, Daniel F. Legler, et al.. (2002). CARMA1 is a critical lipid raft–associated regulator of TCR-induced NF-κB activation. Nature Immunology. 3(9). 836–843. 286 indexed citations
9.
Leyton, Lisette, Pascal Schneider, Curzio Rüegg, et al.. (2001). Thy-1 binds to integrin β3 on astrocytes and triggers formation of focal contact sites. Current Biology. 11(13). 1028–1038. 124 indexed citations
10.
Doucey, Marie‐Agnès, Daniel F. Legler, Nicole Boucheron, et al.. (2001). CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56lck adducts in rafts. European Journal of Immunology. 31(5). 1561–1570. 38 indexed citations
11.
Toni, Nicolas, Pierre‐Alain Buchs, Irina Nikonenko, Claude Bron, & Dominique Müller. (1999). LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature. 402(6760). 421–425. 779 indexed citations breakdown →
12.
Leyton, Lisette, Andrew F. G. Quest, & Claude Bron. (1999). Thy-1/CD3 coengagement promotes TCR signaling and enhances particularly tyrosine phosphorylation of the raft molecule LAT. Molecular Immunology. 36(11-12). 755–768. 30 indexed citations
13.
Romagnoli, Paola & Claude Bron. (1997). GPI-anchored molecules enhance proximal TCR signalling events. Immunology Letters. 56. 64–64. 4 indexed citations
14.
Hahne, Michael, Manuel C. Peitsch, Martin Irmler, et al.. (1995). Characterization of the non-functional Fas ligand of gld mice. International Immunology. 7(9). 1381–1386. 53 indexed citations
16.
Bron, Claude & Nicolás Fasel. (1991). Glycolipid-anchored membrane proteins. IRIS. 2 indexed citations
17.
Fasel, Nicolás, Michel Bernard, Nicole Déglon, et al.. (1991). Isolation from mouse fibroblasts of a cDNA encoding a new form of the fibroblast growth factor receptor (flg). Biochemical and Biophysical Research Communications. 178(1). 8–15. 11 indexed citations
18.
19.
MacDonald, H. Robson, Rosemary K. Lees, Claude Bron, Bernard Sordat, & G Miescher. (1987). T cell antigen receptor expression in athymic (nu/nu) mice. Evidence for an oligoclonal beta chain repertoire.. The Journal of Experimental Medicine. 166(1). 195–209. 76 indexed citations
20.
Budd, Ralph C., J C Cerottini, Claude Bron, et al.. (1987). Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.. The Journal of Immunology. 138(10). 3120–3129. 455 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026